The Department of Veterans Affairs said Friday that it will not halt use of hydroxychloroquine on patients with the coronavirus but said fewer of its patients are now taking it.
Tester, who received VA’s responses this week, said he remained concerned about the drug’s safety.
Jeremy Butler, CEO of Iraq and Afghanistan Veterans of America, said Friday that his group was heartened by the VA’s preliminary explanations and called it imperative that it release additional details. “It remains concerning that it took this long to begin to get answers to basic questions,” he said.
In its response to Congress, the department provided copies of some of its guidance issued to VA physicians on hydroxychloroquine from March to May. It made clear that hydroxychloroquine should be considered mostly for use in clinical trials or when medically appropriate after a full discussion with the patient about risks.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
VA researchers start clinical trials on prostate cancer drug degarelix as possible coronavirus treatmentVA researchers have enrolled 200 veterans in a trial testing whether the prostate cancer drug degarelix could prove to be an effective treatment for men with COVID-19.
Weiterlesen »
VA.gov | Veterans AffairsOne way to protect your mentalhealth during COVID19 is by tracking things that trigger your emotions. If you are a womanveteran, apps like COVID Coach can help you create a plan for good stressmanagement. NWHW
Weiterlesen »
Column: Don't be taken in by stem cell firms offering unsubstantiated therapies for COVID-19Clinics with unproven stem cell treatments are already targeting COVID-19 fears.
Weiterlesen »
How Didier Raoult Became Hydroxychloroquine’s Hype ManVirginia Heffernan talks to writer Scott Sayare about Didier Raoult, the man behind Trump’s favorite unproven treatment for COVID-19.
Weiterlesen »